Rhythm-control vs rate-control in the elderly: When to do it and which drug to prefer?

https://doi.org/10.4081/monaldi.2018.949

Authors

  • Giovanni Luca Botto | gluca.botto@gmail.com ASST Rhodense, Clinical Electrophysiology Unit, Italy.
  • Carlo Piemontese ASST Lariana, Sant’Anna Hospital, Cardiology Unit, Italy.
  • Giovanni Russo ASST Rhodense, Clinical Electrophysiology Unit, Italy.

Abstract

Atrial fibrillation (AF) is a relevant cardiovascular condition that is more prevalent in the elderly patients aged over 65 years. AF, with abnormal rate and rhythm can cause symptoms directly or indirectly by exacerbating other frequently coexisting cardiac conditions such as valvular heart disease, hypertension, ischemic cardiomyopathy, dilated cardiomyopathy, and hypertrophic cardiomyopathy. Evidence suggests that aging-related cardiovascular changes predispose to the elderly to AF. Current therapeutic options such as antiarrhythmic drugs have not been extensively evaluated in the elderly population. Emerging pharmacological and non-pharmacological treatment options for the management of AF, such as dronedarone or catheter ablation, are of particular interest in the elderly. The present paper reviews the pathophysiology, diagnosis, and the management of AF in the elderly patient.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Downloads

Published
2018-06-07
Info
Issue
Section
Cardiology - Original Articles
Keywords:
Atrial fibrillation, rhythm control, rate control, antiarrhythmic drug.
Statistics
  • Abstract views: 3020

  • PDF: 422
How to Cite
Botto, Giovanni Luca, Carlo Piemontese, and Giovanni Russo. 2018. “Rhythm-Control Vs Rate-Control in the Elderly: When to Do It and Which Drug to Prefer?”. Monaldi Archives for Chest Disease 88 (2). https://doi.org/10.4081/monaldi.2018.949.